Inflammation and Epstein–Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection
Recent studies have strengthened the evidence for Epstein–Barr Virus (EBV) as an important contributing factor in the development of multiple sclerosis (MS). Chronic inflammation is a key feature of MS. EBV<sup>+</sup> B cells can express cytokines and exosomes that promote inflammation,...
Main Authors: | Beth A. Rousseau, Sumita Bhaduri-McIntosh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/4/949 |
Similar Items
-
Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative dataResearch in context
by: Omar Yaxmehen Bello-Chavolla, et al.
Published: (2024-02-01) -
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
by: Krystallenia Paniskaki, et al.
Published: (2023-06-01) -
Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis
by: Cyril Debuysschere, et al.
Published: (2023-05-01) -
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
by: Jeffrey E. Gold, et al.
Published: (2021-06-01) -
Chronic active Epstein-Barr exacerbated by COVID-19 co-infection
by: David B Villafuerte, et al.
Published: (2022-09-01)